| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.6 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | -0.015 | 0.6 |
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |